REPL
#2211
Replimune Group, Inc. - Common Stock
15.6 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.76%
Monthly Change
+197.14%
6 month change
+109.12%
Year Change
+191.04%
Previous Close
15.8 8
Open
15.6 0
Low
15.6 0
High
15.6 0
Volume
231
Financials
- Market Capitalization 1.47 B
- Employee 465
- Founded 2015
- CEO N/A
- Website www.replimune.com
- Headquarter Delaware, United States
- FIGI BBG00L8Z22R1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.26
Price to sales ratio
753.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2189 |  INVA Innoviva, Inc. - Common Stock | 20.96 USD | -1.32% | +0.29% | -3.68% | +17.62% | 1.51 B USD | ||
| 2199 |  NVAX Novavax, Inc. - Common Stock | 9.05 USD | -1.74% | +7.23% | +24.14% | +19.71% | 1.49 B USD | ||
| 2219 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 22.60 USD | -1.09% | +4.05% | +28.05% | +195.42% | 1.45 B USD | ||
| 2233 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 13.74 USD | -1.22% | -1.86% | +15.56% | +1.70% | 1.42 B USD |
Frequently asked questions about Replimune Group, Inc.
What is the Replimune Group, Inc. stock price today?
The current price of Replimune Group, Inc. (REPL) is 15.6. Over the past 24 hours, the stock has changed by -1.76%. Follow the REPL chart for real-time price dynamics.
What is the stock ticker of Replimune Group, Inc.?
Replimune Group, Inc. trades under the ticker REPL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Replimune Group, Inc. stock going up?
REPL has changed by +12.55% over the last week, +197.14% over the last month, and +191.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Replimune Group, Inc.?
Replimune Group, Inc. currently has a market capitalization of 1.47 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Replimune Group, Inc. earnings last quarter?
Last quarter, Replimune Group, Inc. reported earnings of -0.72 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Replimune Group, Inc. revenue for the last quarter?
Replimune Group, Inc. reported quarterly revenue of 688 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Replimune Group, Inc. net income for the last quarter?
Replimune Group, Inc. reported net income of -69.77 M for the last quarter. The previous quarter showed -73.22 M, which means net income changed by +4.71%.
How many employees does Replimune Group, Inc. have?
As of the latest available data, Replimune Group, Inc. has 465 employees. Workforce size can provide additional context about the company's scale and operations.
What is Replimune Group, Inc. EBITDA?
Replimune Group, Inc. EBITDA is -66.62 M, and its EBITDA margin is -9 683.43%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Replimune Group, Inc. stock?
You can buy Replimune Group, Inc. (REPL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Replimune Group, Inc. stock?
Investing in Replimune Group, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the REPL chart and related analysis on metatrader.com as part of your research.